Literature DB >> 2566802

Heart failure responding to octreotide in patient with acromegaly.

P Chanson, J Timsit, C Masquet, P J Guillausseau, A Warnet, J Lubetzki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2566802     DOI： 10.1016/s0140-6736(89)92355-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Experiences with octreotide in acromegaly.

Authors:  J A O'Hare; F Abuaisha; T Cotter
Journal:  Ir J Med Sci       Date:  1993-02       Impact factor: 1.568

2.  The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly.

Authors:  Laura De Marinis; Antonio Bianchi; Gherardo Mazziotti; Marco Mettimano; Domenico Milardi; Alessandra Fusco; Vincenzo Cimino; Giulio Maira; Alfredo Pontecorvi; Andrea Giustina
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

3.  Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study.

Authors:  L Ostergaard; L Werdelin; P Odin; O Lindvall; E Dupont; P B Christensen; E Boisen; N B Jensen; S H Ingwersen; M Schmiegelow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

4.  The apomorphine test in parkinsonian syndromes.

Authors:  D F D'Costa; R J Abbott; I F Pye; P A Millac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.